SCHEMBL2246459

SCHEMBL2246459

CCNC(=O)[C@H](C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2246463 1.00
SCHEMBL12955470 1.00
Bromide SCHEMBL11517020 0.97
Hydrochloric Acid SCHEMBL22979248 0.97
Hydrochloric Acid SCHEMBL15792149 0.97
Hydrochloric Acid SCHEMBL15792147 0.97
Phosphonic Acid SCHEMBL11035163 0.91 SLC15A1 (0.40)
SCHEMBL11034167 0.89 SLC15A1 (0.39)
SCHEMBL10954323 0.84 DPP4 (0.45)
Bromide SCHEMBL11517257 0.83 DPP4 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4213969-A Phosphonous acid derivatives, processes for their preparation and their use in combatting microorganisms CIBA-GEIGY CORPORATION (US) 1980-07-22 US claimed
EP-0002039-A1 Phosphonous acid derivatives, processes for their preparation and their use in combating microorganisms CIBA-GEIGY AG (CH) 1979-05-30 EP claimed
US-20260027090-A1 Methods of Inhibiting Osteoclastogenesis and Osteoclast Activity VTV THERAPEUTICS LLC (US) 2026-01-29 US disclosed
US-12091407-B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof VTV THERAPEUTICS LLC (US) 2024-09-17 US disclosed
CN-116891815-A Enteric membrane-like Weissella strain for producing methyl palmitate and application thereof 中国科学院微生物研究所 2023-10-17 CN disclosed
US-20230312548-A1 SUBSTITUTE FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF VTV THERAPEUTICS LLC 2023-10-05 US disclosed
EP-4085769-B1 METHOD FOR IMPROVING AROMA OF CIGARETTE PRODUCT BY USING RASPBERRY KETONE GLUCOSIDE CHINA TOBACCO YUNNAN IND CO LTD (CN) 2023-09-20 EP disclosed
US-11649230-B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof VTV THERAPEUTICS LLC (US) 2023-05-16 US disclosed
US-20230093476-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING REFRACTIVE OCULAR DISORDERS VTV THERAPEUTICS LLC 2023-03-23 US disclosed
EP-4085769-A1 METHOD FOR IMPROVING AROMA OF CIGARETTE PRODUCT BY USING RASPBERRY KETONE GLUCOSIDE CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD (CN) 2022-11-09 EP disclosed
US-20220169641-A1 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof VTVX HOLDINGS II LLC 2022-06-02 US disclosed
US-7300948-B2 Alkynyl compounds as non nucleoside reverse transcriptase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-27 US disclosed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP disclosed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO disclosed
US-6242494-B1 ANGIOGENESIS INHIBITORS, ANTITUMOR AGENTS, DIABETIC RETINOPATHY, AND ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES 2001-06-05 US disclosed
EP-1073633-A2 SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 ABBOTT LABORATORIES (US) 2001-02-07 EP disclosed
WO-1999057098-A2 SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 ABBOTT LABORATORIES (US) 1999-11-11 WO disclosed
US-4554100-A ENZYME INHIBITORS SPOFA, SPOJENE PODNIKY PRO ZDRAVOTNICKOU VYROBU (CS) 1985-11-19 US disclosed
EP-0010872-B1 PROCESS FOR PRODUCING ALPHA-AMINOPHOSPHONIC ACIDS AND THEIR PEPTIDES AND COMPOUNDS THUS OBTAINED CIBA-GEIGY AG (CH) 1983-05-25 EP disclosed
US-4062835-A LUTEINIZING HORMONE RELEASE ANTAGONISTS PARKE, DAVIS & COMPANY (US) 1977-12-13 US disclosed